Perlegen, Pfizer collaboration to analyze patient DNA samples

The whole-genome association studies will examine, for instance, hundreds of patients with a specific "trait of interest" of either having a particular disease or particular responsiveness to a drug. The research will scan across the entire genome to identify SNPs and genetic variance among the patients to identify the associations and then following up the findings with validation studies.